News for 'pharmaceuticals'

US calls India-EU trade deal 'very disappointing'

US calls India-EU trade deal 'very disappointing'

Rediff.com29 Jan 2026

In the wake of the FTA between India and the European Union, the United States has described the Europeans as 'very disappointing', saying they were unwilling to join Washington, DC in putting tariffs on New Delhi for its purchases of Russian oil because of this trade deal.

Dr Reddy's profit down 14% on low Lenalidomide US sales

Dr Reddy's profit down 14% on low Lenalidomide US sales

Rediff.com22 Jan 2026

Pharma major Dr Reddy's Laboratories (DRL) reported a 14 per cent year-on-year (Y-o-Y) drop in consolidated net profit to Rs 1,210 crore in the December quarter of FY 2025-26 (Q3FY26) on low sales of cancer drug Lenalidomide in the North American market. The firm's revenue from operations grew to Rs 8,727 crore in Q3FY26, a 4.4 per cent Y-o-Y increase from Rs 8,357 crore recorded for the same quarter last year.

Domestic sales a booster dose for pharma revenues

Domestic sales a booster dose for pharma revenues

Rediff.com19 Jan 2026

Buoyant domestic sales are expected to lift revenues for pharma companies by 8-11 per cent in Q3FY26, even as declining generic Revlimid (cancer drug) sales in the US remain a key drag. Most brokerages forecast a modest 2-4 per cent growth in profit after tax (PAT) for the quarter. Hospitals and diagnostics companies, meanwhile, are likely to post much stronger numbers, with revenues seen growing 20-22 per cent year-on-year (Y-o-Y).

Trouble for India? Trump announces 25% tariff on Iran's trade partners

Trouble for India? Trump announces 25% tariff on Iran's trade partners

Rediff.com13 Jan 2026

Trump said that the decision would be "immediately" in effect and that the "order is final and conclusive."

Explained: How FTA with EU will help boost India's exports

Explained: How FTA with EU will help boost India's exports

Rediff.com28 Jan 2026

India and the European Union (EU) on Tuesday announced the conclusion and finalisation of negotiations for the proposed free trade agreement (FTA).

Want To Study At The University Of Surrey?

Want To Study At The University Of Surrey?

Rediff.com23 Dec 2025

The International Excellence Scholarship (Postgraduate) 2026 aims to help students from financially challenged backgrounds with their college education.

India's trade deficit with China may reach $106 billion in 2025: GTRI

India's trade deficit with China may reach $106 billion in 2025: GTRI

Rediff.com19 Dec 2025

India's trade deficit with China is expected to reach $106 billion in 2025 as imports are rising faster than the country's exports to the neighbouring country, think tank GTRI said on Friday.

'No Indian company will be...': Tharoor on Trump's Iran tariffs

'No Indian company will be...': Tharoor on Trump's Iran tariffs

Rediff.com15 Jan 2026

The Congress MP said he had been "troubled" by the US tariff regime from the very beginning, adding that India was already at a disadvantage compared to its regional competitors.

10 Stocks That May Gain From Budget

10 Stocks That May Gain From Budget

Rediff.com4 Feb 2026

The fiscal tilt towards capex benefits companies in investment-related sectors like capital goods, defence equipment, engineering & construction and metal & mining. The planned cut in revenue expenditure will weigh on companies in consumption sectors like FMCG, consumer durables and retail.

'Budget Likely To Be Non-Event For Markets'

'Budget Likely To Be Non-Event For Markets'

Rediff.com31 Jan 2026

'When markets go into a budget with excessive optimism, the risk of disappointment is higher.'

Meet The 'Waste Warrior' Of India!

Meet The 'Waste Warrior' Of India!

Rediff.com5 Feb 2026

Her mission: Making Mother Earth cleaner and greener!

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Rediff.com1 Feb 2026

Budget 2026 sticks to fiscal discipline, shuns populist measures despite five key state elections coming up, but ends up rattling stock markets with a higher transaction tax on derivatives trading.

India, New Zealand conclude FTA negotiations

India, New Zealand conclude FTA negotiations

Rediff.com22 Dec 2025

New Zealand Prime Minister Christopher Luxon on Monday said the negotiations for a free trade agreement with India have been concluded.

TN special teams to monitor drug firms after cough syrup deaths

TN special teams to monitor drug firms after cough syrup deaths

Rediff.com17 Oct 2025

Tamil Nadu has formed special teams to monitor drug manufacturers after deaths of infants in Madhya Pradesh were linked to a cough syrup made by a Tamil Nadu-based company. Inspections are being conducted at pharmaceutical firms across the state.

UP cracks down on illegal cough syrup trade, 75 arrested

UP cracks down on illegal cough syrup trade, 75 arrested

Rediff.com20 Dec 2025

Uttar Pradesh authorities have registered 74 cases and arrested 75 people in connection with the illegal storage and sale of codeine-based cough syrup. A minister alleges links to the Samajwadi Party and an SIT is investigating.

Venezuela Turmoil Unlikely To Rattle India's Trade

Venezuela Turmoil Unlikely To Rattle India's Trade

Rediff.com12 Jan 2026

'The immediate impact for India will be very minimal as the share of Venezuela in our total overseas production is very low.'

'India Should Not Rush To Celebrate Trump's Trade Announcement'

'India Should Not Rush To Celebrate Trump's Trade Announcement'

Rediff.com3 Feb 2026

'Trump says India will buy over $500 billion of US goods.' 'At present, India's annual imports of goods and energy from the US are under $50 billion.' 'Reaching $500 billion would likely require more than 20 years, suggesting the figure refers to a long-term aspiration rather than a near-term commitment.'

Will India continue to remain an attractive FDI destination in 2026?

Will India continue to remain an attractive FDI destination in 2026?

Rediff.com27 Dec 2025

FDI inflows into India are expected to register robust growth in 2026, supported by strong macroeconomic fundamentals, big-ticket investment announcements, sustained efforts to improve the ease of doing business, and a new generation of investment-linked trade pacts.

8 Of India's Oldest Companies

8 Of India's Oldest Companies

Rediff.com11 Nov 2025

Which were India's first companies that still exist today? Many trace their origins to over a century back. These venerable organisations are business entities. But they chronicle the beginnings of Corporate India.

Dr Reddy's Laboratories loses Rs 2.16 cr in cyber fraud

Dr Reddy's Laboratories loses Rs 2.16 cr in cyber fraud

Rediff.com10 Nov 2025

The Bengaluru police have launched a probe into a cyber fraud case where hackers allegedly infiltrated the official email communication between city-based Group Pharmaceuticals and Dr Reddy's Laboratories, Hyderabad, successfully diverting a payment of Rs 2.16 crore to a fraudulent account.

India's Billionaire Club Shrinks in 2025

India's Billionaire Club Shrinks in 2025

Rediff.com8 Jan 2026

The 2025 contraction marks the steepest decline in both the number of billionaire promoters and their aggregate wealth since 2012.

TN govt revokes license for Coldrif cough syrup; shuts down firm

TN govt revokes license for Coldrif cough syrup; shuts down firm

Rediff.com13 Oct 2025

The Enforcement Directorate (ED) raided premises linked to Sresan Pharmaceuticals, the manufacturer of Coldrif cough syrup linked to the deaths of children in Madhya Pradesh and Rajasthan, and top officials of the Tamil Nadu FDA as part of a money laundering investigation.

Cancer Therapies Break New Ground

Cancer Therapies Break New Ground

Rediff.com26 Dec 2025

'India is clearly moving toward more targeted treatment pathways in high-burden cancers.'

World's 9 Fastest-Growing Cities

World's 9 Fastest-Growing Cities

Rediff.com26 Dec 2025

Asia takes the lead, boasting four Indian cities on the list, according to the 2024 Savills Growth Hubs Index.

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.

Healthcare IPOs See A Surge In 2025

Healthcare IPOs See A Surge In 2025

Rediff.com8 Jan 2026

The surge has come alongside a decline in average issue sizes and more muted listing-day returns compared with last year.

Trump announces 100% tariffs on foreign-made movies, India to be hit

Trump announces 100% tariffs on foreign-made movies, India to be hit

Rediff.com29 Sep 2025

President Trump announces 100% tariffs on movies made outside the US, potentially impacting the Indian film industry. The move follows similar tariffs on pharmaceutical products.

India Inc's profits relative to capital employed at 14-yr high

India Inc's profits relative to capital employed at 14-yr high

Rediff.com22 Dec 2025

Companies are squeezing more profits from their operations relative to the capital they put to work, the highest now since 2011. Profit after tax relative to capital employed came in at 10.47 per cent in September, shows data from the Centre for Monitoring Indian Economy (CMIE), higher than the 8.41 per cent seen in September last year. This is the highest since March 2010.

Biocon launches diabetes & obesity drugs in Netherlands

Biocon launches diabetes & obesity drugs in Netherlands

Rediff.com16 Dec 2025

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.

Kapil Sharma-Priyanka Provide The Laughs On OTT

Kapil Sharma-Priyanka Provide The Laughs On OTT

Rediff.com19 Dec 2025

It's raining sequels on OTT this week, but that's not all. Sukanya Verma lists everything you can watch.

Sensex down 275 points on fag-end selling

Sensex down 275 points on fag-end selling

Rediff.com10 Dec 2025

Among the Sensex constituents, Eternal, Trent, Bharti Airtel, Infosys, Tech Mahindra, UltraTech Cement, ICICI Bank, HDFC Bank, Bajaj Finance, Tata Consultancy Services, Bharat Electronics Ltd, Larsen & Toubro and Tata Motors Passenger Vehicles were the laggards. However, Tata Steel, Sun Pharmaceuticals, ITC, NTPC, Reliance Industries, HCL Technologies, PowerGrid, and Asian Paints were among the gainers.

Sensex jumps 427 points on buying in metal, auto shares

Sensex jumps 427 points on buying in metal, auto shares

Rediff.com11 Dec 2025

Among the Sensex constituents, Eternal, Tata Steel, Kotak Mahindra Bank, UltraTech Cement, Maruti Suzuki India, Sun Pharmaceuticals, Tech Mahindra, HDFC Bank, Tata Motors Passenger Vehicles, Infosys, Trent, Mahindra & Mahindra, Reliance Industries and HCL Technologies were the gainers. However, Asian Paints, Bharti Airtel, Bajaj Finance, PowerGrid, Axis Bank, ICICI Bank and Titan were among the laggards.

What Weapons Will Putin Sell India On Rare State Visit?

What Weapons Will Putin Sell India On Rare State Visit?

Rediff.com29 Nov 2025

On the table are additional batches of S-400 surface-to-air missile systems from Russia, which India used with immense success during Operation Sindoor. India could buy at least two squadrons of Su-57 fighter jets plus joint production of S-500 air defence systems.

Rupee Fall: Who Stands To Gain?

Rupee Fall: Who Stands To Gain?

Rediff.com25 Nov 2025

So far this year, the rupee has fallen by 4.2 per cent, the worst among its Asian peers.

Mumbai businesswoman stripped, filmed at gunpoint in pharma firm office

Mumbai businesswoman stripped, filmed at gunpoint in pharma firm office

Rediff.com1 Dec 2025

As per the FIR, the woman was called to the company's office, where she was allegedly assaulted and stripped.

Sensex rises 329 pts on rally in pharma, banking shares

Sensex rises 329 pts on rally in pharma, banking shares

Rediff.com10 Oct 2025

Among the Sensex firms, State Bank of India, Maruti Suzuki India, Axis Bank, NTPC, BEL, Adani Ports, Eternal, Sun Pharmaceuticals, Power Grid, ITC, UltraTech Cement, Trent, HCL Technologies, Mahindra & Mahindra, and HDFC Bank were the major gainers. On the other hand, Tata Steel, Tata Consultancy Services, Tech Mahindra, Titan, Bajaj Finserv, Tata Motors, Bharti Airtel and Bajaj Finance were among the laggards.

Odisha leads in GST growth, T'gana in direct taxes

Odisha leads in GST growth, T'gana in direct taxes

Rediff.com26 Dec 2025

A shift appears underway in India's tax landscape. States with relatively smaller tax collections like Odisha and Telangana are emerging as the fastest-growing contributors to indirect and direct tax collections, respectively.

FDA raids 20 pharmacies in Pune over illegal cough syrup sales

FDA raids 20 pharmacies in Pune over illegal cough syrup sales

Rediff.com10 Oct 2025

Following deaths allegedly linked to contaminated cough syrup, Pune FDA initiates action against pharmacies selling without prescriptions and prohibits stock from a Gujarat-based firm.

US lawmakers move resolution to end Trump tariffs on India

US lawmakers move resolution to end Trump tariffs on India

Rediff.com13 Dec 2025

Representatives Deborah Ross of North Carolina, Marc Veasey of Texas and Raja Krishnamoorthi of Illinois introduced the resolution on Friday in the House of Representatives to terminate Trump's national emergency authorising tariffs of up to 50 per cent on imports from India, helping to restore Congress' constitutional authority over trade.

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Rediff.com26 Sep 2025

Most pharma shares dropped, dragging the BSE Healthcare index down by 2.14 per cent after Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1. Wockhardt shares tanked 9.4 per cent.